3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Interventions
neratinib
1
bemarituzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Urinary Bladder Neoplasms
×
bemarituzumab
×
Clear all
NCT03801278
2021-12-13
FPA144
Five Prime Therapeutics, Inc.
No longer available